Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4063430
Max Phase: Preclinical
Molecular Formula: C43H53ClN12O6
Molecular Weight: 869.43
Molecule Type: Small molecule
Associated Items:
ID: ALA4063430
Max Phase: Preclinical
Molecular Formula: C43H53ClN12O6
Molecular Weight: 869.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)NN(Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
Standard InChI: InChI=1S/C43H53ClN12O6/c1-26(51-41(60)37(20-29-22-49-34-12-6-5-11-32(29)34)53-40(59)33(46)21-31-23-48-25-50-31)39(58)55-56(24-28-14-16-30(44)17-15-28)43(62)54-36(19-27-9-3-2-4-10-27)42(61)52-35(38(47)57)13-7-8-18-45/h2-6,9-12,14-17,22-23,25-26,33,35-37,49H,7-8,13,18-21,24,45-46H2,1H3,(H2,47,57)(H,48,50)(H,51,60)(H,52,61)(H,53,59)(H,54,62)(H,55,58)/t26-,33-,35-,36+,37+/m0/s1
Standard InChI Key: OKSZFHMXHJBINK-MHKQCRJVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 869.43 | Molecular Weight (Monoisotopic): 868.3900 | AlogP: 1.60 | #Rotatable Bonds: 21 |
Polar Surface Area: 288.34 | Molecular Species: BASE | HBA: 9 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.34 | CX Basic pKa: 9.97 | CX LogP: 0.08 | CX LogD: -2.50 |
Aromatic Rings: 5 | Heavy Atoms: 62 | QED Weighted: 0.04 | Np Likeness Score: -0.23 |
1. Chignen Possi K, Mulumba M, Omri S, Garcia-Ramos Y, Tahiri H, Chemtob S, Ong H, Lubell WD.. (2017) Influences of Histidine-1 and Azaphenylalanine-4 on the Affinity, Anti-inflammatory, and Antiangiogenic Activities of Azapeptide Cluster of Differentiation 36 Receptor Modulators., 60 (22): [PMID:29028172] [10.1021/acs.jmedchem.7b01209] |
Source(1):